Allogeneic double‐negative T cell therapy for relapsed <scp>acute myeloid leukemia</scp> patients post <scp>allogeneic hematopoietic stem cell transplantation</scp>: A first‐in‐human phase I studyBaolin Tang, Xiaoyu Zhu, Wen Yao et al.|American Journal of Hematology|2022Cited by 26
Anti-PD-1 therapy-induced aGvHD is associated with abnormal IL-1β and NKG2A level in AML patients with relapse post-UCBTXiaoyu Zhu, Li Xu, Dongyao Wang et al.|Research Square|2024Cited by 0